1,256 results on '"Pisetsky, David S"'
Search Results
2. Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study
3. Pathogenesis of autoimmune disease
4. Highlights from the 2024 Rheumatoid Arthritis Research Summit
5. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis
6. Moonlighting chromatin: when DNA escapes nuclear control
7. The expression of antibodies to Z-DNA in the blood of patients with systemic lupus erythematosus: Relationship to autoantibodies to B-DNA
8. Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus
9. The Impact of Antinuclear Antibody Testing on the Naming and Misnaming of Disease
10. Mixed-surface polyamidoamine polymer variants retain nucleic acid-scavenger ability with reduced toxicity
11. Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus.
12. Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis
13. The role of DNA in the pathogenesis of SLE: DNA as a molecular chameleon
14. DNA corona on nanoparticles leads to an enhanced immunostimulatory effect with implications for autoimmune diseases
15. The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding
16. The binding of SLE autoantibodies to mitochondria
17. The Binding Properties of Antibodies to Z-DNA in the Sera of Normal Healthy Subjects
18. The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus
19. Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study
20. New insights into the role of antinuclear antibodies in systemic lupus erythematosus
21. Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.
22. The Role of Microparticles as Biomarkers in the Development of Therapy for Autoimmune Disease
23. Are DNA–HLA class II interactions the missing link in SLE?
24. A Holistic Approach to Pain Management in the Rheumatic Diseases
25. The Induction of Matrix Metalloproteinase and Cytokine Expression in Synovial Fibroblasts Stimulated with Immune Cell Microparticles
26. Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers
27. In relapsing AAV with rituximab-induced remission, maintenance rituximab vs. azathioprine reduced relapse at ≥32 mo
28. 237 - Laboratory Testing in the Rheumatic Diseases
29. List of Contributors
30. Lupus Biomarkers
31. Antibodies to Neutrophil Extracellular Traps: Novel Markers for the Antiphospholipid Syndrome
32. Role of complement activation in cellular activation by systemic lupus erythematosus (SLE) immune complexes (ICs)
33. The role of monogamous bivalency and Fc interactions in the binding of anti-DNA antibodies to DNA antigen
34. The Alarmin Properties of DNA and DNA-associated Nuclear Proteins
35. Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis
36. In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk
37. Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II , Randomized, Double‐Blind , Placebo‐Controlled Dose‐Ranging Trial
38. 1803 The clinical characteristics of SLE patients with increased levels of cell-bound complement activation products
39. 624 The Molecular Endotypes of Type 1 and Type 2 SLE
40. 615 A pilot study to implement the Type 1 & 2 SLE Model into clinical care
41. Antinuclear antibody testing — misunderstood or misbegotten?
42. The Immunopathogenesis and Immunopathology of Systemic Lupus Erythematosus
43. Gamow, Guppies, and the Search for GOD
44. The Molecular Endotypes of Type 1 and Type 2 SLE
45. The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells
46. Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms.
47. Anti-DNA antibodies — quintessential biomarkers of SLE
48. Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
49. Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa
50. The Antigenicity of Bacterial DNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.